Drug Profile
Morphine immediate-release - Ensysce Biosciences
Alternative Names: PFR 03318Latest Information Update: 30 Aug 2023
Price :
$50
*
At a glance
- Originator Ensysce Biosciences
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 30 Aug 2023 Discontinued - Preclinical for Pain in USA (PO, Immediate release) (Ensysce Biosciences pipeline, August 2023)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Pain in USA (PO, Immediate release)
- 24 Feb 2016 Preclinical trials in Pain in USA (PO) before February 2016